Abstract
Objectives
Determine the proportion of malignancy within Bosniak v2019 classes.
Methods
MEDLINE and EMBASE were searched. Eligible studies contained patients with cystic renal masses undergoing CT or MRI renal protocol examinations with pathology confirmation, applying Bosniak v2019. Proportion of malignancy was estimated within Bosniak v2019 class. Risk of bias was assessed using QUADAS-2.
Results
We included 471 patients with 480 cystic renal masses. No class I malignant masses were observed. Pooled proportion of malignancy were class II, 12% (6/51, 95% CI 5–24%); class IIF, 46% (37/85, 95% CI 28–66%); class III, 79% (138/173, 95% CI 68–88%); and class IV, 84% (114/135, 95% CI 77–90%). Proportion of malignancy differed between Bosniak v2019 II–IV classes (p = 0.004). Four studies reported the proportion of malignancy by wall/septa feature. The pooled proportion of malignancy with 95% CI were class III thick smooth wall/septa, 77% (41/56, 95% CI 53–91%); class III obtuse protrusion ≤ 3 mm (irregularity), 83% (97/117, 95% CI 75–89%); and class IV nodule with acute angulation, 86% (50/58, 95% CI 75–93%) or obtuse angulation ≥ 4 mm, 83%, (64/77, 95% CI 73–90%). Subgroup analysis by wall/septa feature was limited by sample size; however, no differences were found comparing class III masses with irregularity to class IV masses (p = 0.74) or between class IV masses by acute versus obtuse angles (p = 0.62).
Conclusion
Preliminary data suggest Bosniak v2019 class IIF masses have higher proportion of malignancy compared to the original classification, controlling for pathologic reference standard. There are no differences in proportion of malignancy comparing class III masses with irregularities to class IV masses with acute or obtuse nodules.
Key Points
• The proportion of malignancy in Bosniak v2019 class IIF cystic masses is 46% (37 malignant/85 total IIF masses, 95% confidence intervals (CI) 28–66%).
• The proportion of malignancy in Bosniak v2019 class III cystic masses is 79% (138/173, 95% CI 68–88%) and in Bosniak v2019 class IV cystic masses is 84% (114/135, 95% CI 77–90%).
• Class III cystic masses with irregularities had similar proportion of malignancy (83%, 97/117, 95% CI 75–89%) compared to Bosniak class IV masses (84%, 114/135, 95% CI 77–90%) overall (p = 0.74) with no difference within class IV masses by acute versus obtuse angulation (p = 0.62).
Similar content being viewed by others
Abbreviations
- Bosniak v2019:
-
Bosniak Classification of Cystic Renal Masses version 2019
- CI:
-
Confidence interval
- III-OP:
-
Bosniak class III mass with obtuse protrusion ≤ 3 mm (irregularity)
- III-WS:
-
Bosniak class III mass with wall or septa thickening
- IV-AP:
-
Bosniak class IV mass with acute protrusion of any size
- IV-OP:
-
Bosniak class IV mass with obtuse protrusion ≥ 4 mm
- PRISMA-DTA:
-
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies
- QUADAS-2:
-
Quality Assessment of Diagnostic Accuracy Studies 2
References
Silverman SG, Pedrosa I, Ellis JH et al (2019) Bosniak Classification of Cystic Renal Masses, version 2019: an update proposal and needs assessment. Radiology. https://doi.org/10.1148/radiol.2019182646:182646
Bai X, Sun SM, Xu W et al (2020) MRI-based Bosniak Classification of Cystic Renal Masses, version 2019: interobserver agreement, impact of readers’ experience, and diagnostic performance. Radiology. https://doi.org/10.1148/radiol.2020200478:200478
Tse JR, Shen J, Yoon L, Kamaya A (2020) Bosniak classification version 2019 of cystic renal masses assessed with MRI. AJR Am J Roentgenol 215:413–419
Yan JH, Chan J, Osman H et al (2021) Bosniak classification version 2019: validation and comparison to original classification in pathologically confirmed cystic masses. Eur Radiol. https://doi.org/10.1007/s00330-021-08006-5
Pacheco EO, Torres US, Alves AMA, Bekhor D, D’Ippolito G (2020) Bosniak Classification of Cystic Renal Masses version 2019 does not increase the interobserver agreement or the proportion of masses categorized into lower Bosniak classes for non-subspecialized readers on CT or MR. Eur J Radiol 131:109270
Shampain KL, Shankar PR, Troost JP et al (2021) Interrater agreement of bosniak classification version 2019 and version 2005 for cystic renal masses at CT and MRI. Radiology. https://doi.org/10.1148/radiol.2021210853:210853
Tse JR, Shen L, Shen J, Yoon L, Kamaya A (2020) Prevalence of malignancy and histopathologic association of Bosniak classification, version 2019 class III and IV cystic renal masses. J Urol. https://doi.org/10.1097/JU.0000000000001438:101097JU0000000000001438
Park MY, Park KJ, Kim MH, Kim JK (2021) Bosniak Classification of Cystic Renal Masses version 2019: comparison with version 2005 for class distribution, diagnostic performance, and interreader agreement using CT and MRI. AJR Am J Roentgenol 217:1367–1376
Smith AD (2021) Bosniak Classification version 2019: counterpoint-it’s complicated. AJR Am J Roentgenol. https://doi.org/10.2214/AJR.21.26834
Eble JN SG, Epstein JI, Sesterhenn IA (2004) World Health Organization classification of tumors: pathology and genetics of tumors of the urinary system and male genital organs. Lyon, Fr. Available via http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb7/BB7.pdf2013. Accessed 25 Nov 2021
Deeks J, Bossuyt P, Gatsonis C (2013) Cochrane handbook for systematic reviews of diagnostic test accuracy version 1.0. The Cochrane Collaboration, London
McGrath TA, Bossuyt PM, Cronin P et al (2018) Best practices for MRI systematic reviews and meta-analyses. J Magn Reson Imaging. https://doi.org/10.1002/jmri.26198
McInnes MDF, Moher D, Thombs BD et al (2018) Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: the PRISMA-DTA statement. JAMA 319:388–396
Israel GM, Hindman N, Bosniak MA (2004) Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231:365–371
Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-Part A: Renal, penile, and testicular tumours. Eur Urol 70:93–105
Li T, Chen J, Jiang Y et al (2016) Multilocular cystic renal cell neoplasm of low malignant potential: a series of 76 cases. Clin Genitourin Cancer 14:e553–e557
McGrath TA, McInnes MDF, Langer FW, Hong J, Korevaar DA, Bossuyt PMM (2017) Treatment of multiple test readers in diagnostic accuracy systematic reviews-meta-analyses of imaging studies. Eur J Radiol 93:59–64
Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536
McGrath TA, Shoeib A, Davenport MS, Silverman SG, McInnes MDF, Schieda N (2021) Evaluation of class II cystic renal masses proposed in Bosniak classification version 2019: a systematic review of supporting evidence. Abdom Radiol (NY) 46:4888–4897
Schoots IG, Zaccai K, Hunink MG, Verhagen P (2017) Bosniak classification for complex renal cysts reevaluated: a systematic review. J Urol 198:12–21
Sevcenco S, Spick C, Helbich TH et al (2017) Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography - a systematic review and meta-analysis. Eur Radiol 27:2239–2247
Sefik E, Bozkurt IH, Adibelli ZH et al (2019) The histopathologic correlation of Bosniak 3 cyst subclassification. Urology 129:126–131
Schieda N, Krishna S, Pedrosa I, Kaffenberger SD, Davenport MS, Silverman SG (2021) Active Surveillance of Renal Masses: The Role of Radiology. Radiology. https://doi.org/10.1148/radiol.2021204227:204227
Funding
Dr. McInnes and Dr. Schieda were supported by the University of Ottawa Department of Radiology Research Stipend Program. No other authors have relevant funding. None of the funding bodies listed had any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Dr Nicola Schieda.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
One of the authors has significant statistical expertise (Matthew McInnes). No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the Institutional Review Board at our institution for this type of study.
Ethical approval
Institutional Review Board approval was not required because of study type.
Methodology
• Systematic review
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 22 kb)
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
McGrath, T.A., Bai, X., Kamaya, A. et al. Proportion of malignancy in Bosniak classification of cystic renal masses version 2019 (v2019) classes: systematic review and meta-analysis. Eur Radiol 33, 1307–1317 (2023). https://doi.org/10.1007/s00330-022-09102-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-022-09102-w